Home > Boards > US Listed > Medical - Drugs >

AIkido Pharma Inc (AIKI)

AIKI RSS Feed
Add AIKI Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 11/23/2021 11:26:13 AM - Followers: 176 - Board type: Free - Posts Today: 0




https://aikidopharma.com/published-papers/

KPC-34

Kucera Paper A novel phospholipid gemcitabine conjugate is able to bypass three drug-resistance mechanisms

Kucera Paper Lipid Nucleoside Conjugates for the Treatment of Cancer

Kucers & Pardee Paper Improving Nucleoside Analogs via Lipid Conjugation

Short Summary of KPC34

The Phospholipid Gemcitabine Conjugate, KPC34, is a Novel Treatment for Leukemia

Wake Forest School of Medicine Study Phospholipiddeoxycytidine analogue prodrugs for the treatment of cancer

DHA-dFdC

Short-term Toxicity Study of DHA-dFdC

Study of DHA-dFdC

Synthesis and Cytotoxic Activity of Two Novel 1-Dodecylthio-2-decyloxypropyl-3-phosphatidic Acid Conjugates with Gemcitabine and Cytosine Arabinoside

Investor Relations.

AIkido Pharma Inc. seeks to enhance shareholder value not only through exceptional business performance and practices,
but also through responsible and effective communication with its shareholders. The latest company information relevant to the individual
and institutional investor includes stock price and history, upcoming events and presentations and financial documents.
AIkido Pharma Inc. is traded on the Nasdaq under the ticker symbol AIKI.

Overview.

AIkido Pharma Inc. is a biotechnology development company with a diverse portfolio of early stage small-molecule anti-cancer therapeutics.
The Spherix platform contains patented technology from leading universities and researchers and we seek to develop
our innovative drugs through strong partnership with world renowned institutions, such as The University of Texas and Wake Forest University.
Our diverse pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL).
Our pancreatic treatment has shown positive preclinical results for inhibiting pancreatic tumor growth in clinically relevant transgenic mouse models.
The drug has also demonstrated the potential to overcome tumor cell resistance to current chemotherapeutic drugs.
Our AML drug is a next generation targeted therapeutic designed to overcome multiple resistance mechanisms observed with the current standard of care.
In addition, we are constantly seeking to grow our pipe to treat unmet medical needs in oncology.

https://ir.aikidopharma.com/stock-information/

$AIKI Spherix Incorporated, a biotechnology company,focuses on developing small-molecule anti-cancer therapeutics.
Its pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.
The company's platform consists of patented technology from leading universities and researchers and in the process of developing an
innovative therapeutic drug platform through partnerships with world renowned educational institutions, including The University of Texas at
Austin and Wake Forest University.
It has a scientific research agreement with The University of Texas Southwestern Medical Center to use machine learning to find genetic
markers in people that indicate an increased risk of developing pancreatic cancer.
Spherix Incorporated was founded in 1967 and is based in New York, New York.

$AIKI
https://aikidopharma.com/
https://aikidopharma.com/about/
https://aikidopharma.com/portfolio/
https://aikidopharma.com/portfolio/aml-all/
https://aikidopharma.com/portfolio/pancreatic-cancer/
https://aikidopharma.com/scientific-advisory-board/
https://aikidopharma.com/published-papers/
https://ir.aikidopharma.com/

About
AIkido Pharma Inc. .
AIkido Pharma Inc. is a biotechnology development company with a diverse portfolio of early stage small-molecule anti-cancer therapeutics.

The AIkido Pharma Inc. platform contains patented technology from leading universities and researchers and
we seek to develop our innovative drugs through strong partnership with world renowned institutions,
such as The University of Texas and Wake Forest University.


Our diverse pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia (AML),
and acute lymphoblastic leukemia (ALL). Our pancreatic treatment has shown positive preclinical results for
inhibiting pancreatic tumor growth in clinically relevant transgenic mouse models.


The drug has also demonstrated the potential to overcome tumor cell resistance to current chemotherapeutic drugs.
Our AML drug is a next generation targeted therapeutic designed to overcome multiple resistance mechanisms
observed with the current standard of care. In addition,
we are constantly seeking to grow our pipe to treat unmet medical needs in oncology.







https://www.otcmarkets.com/stock/AIKI/disclosure

https://www.otcmarkets.com/stock/AIKI/news

https://www.otcmarkets.com/stock/AIKI/security

https://www.otcmarkets.com/stock/AIKI/profile

https://www.otcmarkets.com/stock/AIKI/quote

https://www.otcmarkets.com/stock/AIKI/overview



*DISCLAIMER *The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
• We do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.






 
AIKI
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#8264   Get ready for the buttered popcorn... db101 11/23/21 11:26:13 AM
#8263   AIKI...73...Bullish 3 Gap Downs Reversal Pattern to the georgie18 11/23/21 05:43:07 AM
#8262   Looks like good news AlKl White Lightning 11/12/21 01:32:00 PM
#8261   AIkido owns 525,000 shares of DatChat, which it [SMART MONEY] 10/12/21 07:15:58 PM
#8260   AIKI...92...on the P/M Gappa...:partying_face: georgie18 10/11/21 08:08:31 AM
#8259   Impressed with the CEO management taking investment stakes urge2surge 09/29/21 09:10:34 PM
#8258   Interesting, low ss here... TGOO 09/29/21 12:42:11 PM
#8257   Very volatile but looks ready Sirpeter 09/29/21 12:27:36 PM
#8256   Added let’s see what this can do sportd 09/29/21 11:35:21 AM
#8255   Kaboom! Sirpeter 09/29/21 11:33:33 AM
#8254   Bullish Sirpeter 09/29/21 11:28:08 AM
#8253   Would be nice... it has been ages since antman 09/16/21 10:57:42 PM
#8252   AIkido Pharma Releases Shareholder Update; Near Term Catalysts Approaching db101 09/14/21 11:20:20 AM
#8251   News... db101 09/14/21 09:46:18 AM
#8250   AIKI...86...Tue, July 27, 2021, 10:00 AM georgie18 07/27/21 10:11:10 AM
#8249   AIKI...97...Bounce off the .85 range on the Bullish georgie18 07/22/21 06:39:01 AM
#8248   $1.10 nice wesley_ 06/23/21 10:07:25 AM
#8247   No respect from the street on this company. urge2surge 06/17/21 08:48:47 AM
#8246   Yeah definitely under substantial book value here. Not urge2surge 06/05/21 09:03:11 AM
#8245   BULLISH RESEARCH ARTICLE! Trading under cash and great Chess Master 06/04/21 12:49:52 PM
#8244   * * $AIKI Video Chart 04-21-2021 * * ClayTrader 04/21/21 05:12:01 PM
#8243   AIKI...86...NEW YORK, April 16, 2021 /PRNewswire/ -- AIkido georgie18 04/16/21 10:17:20 AM
#8242   AIKI...$1.20...in the P/M...NEW YORK, April 7, 2021 /PRNewswire/ georgie18 04/07/21 09:25:54 AM
#8241   AIKI...$1.17...Bidding the Lower Band to the 20ma to georgie18 04/03/21 09:27:00 AM
#8240   AIKI...$1.17...in the P/M...https://www.otcmarkets.com/stock/AIKI/news/story?e&i georgie18 03/29/21 09:25:57 AM
#8239   $aiki $1.17 ? 0.0 (0.00%) Taurus69 03/28/21 02:57:47 PM
#8238   * * $AIKI Video Chart 03-24-2021 * * ClayTrader 03/24/21 05:49:51 PM
#8237   Do VMHG next. Heel Hulk 03/15/21 06:16:52 PM
#8236   * * $AIKI Video Chart 03-15-2021 * * ClayTrader 03/15/21 05:33:09 PM
#8235   https://www.stockwatch.com/News/Item/U-prNY08103-U!AIKI-20210312/U/AIKI[/ur antman 03/12/21 11:49:43 AM
#8234   Today should be good for AIKI antman 03/09/21 06:57:46 AM
#8233   Come on AIKI- for pete's sake! antman 03/05/21 02:35:42 PM
#8232   News out yesterday. Closed up. AIkido Pharma Inc. billionsmatter 03/02/21 07:55:45 AM
#8231   $aiki $1.19 v -0.04 (-3.25%) Taurus69 02/26/21 08:29:58 PM
#8230   AIKI mentioned in this Magic Mushroom article https://insiderfinancial.com/eight BugStocks_com 02/22/21 02:37:18 PM
#8229   On January 12, 2021, AIkido Pharma Inc., a nuclear profitz 02/22/21 11:19:04 AM
#8228   I think the big boys are here now. nathanial 02/21/21 06:05:18 PM
#8227   47mm shares from the offering. Be about 80mm BlindSquirrelFindsNuts 02/21/21 06:00:16 PM
#8226   Alkido Pharma Inc (AIKI) mick 02/21/21 05:49:52 PM
#8225   How can you R/S a stock with nathanial 02/21/21 05:49:00 PM
#8224   I saw in the filings they extended the nathanial 02/21/21 05:45:44 PM
#8223   There is a PR on my TOS TDA Billybob_TX 02/21/21 05:16:37 PM
#8222   Gan,I play it csndle by candle so we georgie18 02/21/21 08:04:11 AM
#8221   georgi18, Thanks for your TA on this.. Gan 02/20/21 08:35:03 PM
#8220   Is there any link, filing or PR stating nathanial 02/20/21 07:13:55 PM
#8219   10k @ 1.58 for me :) STOCKSnGLOCKS 02/19/21 11:23:14 AM
#8218   There was nearly a million totalled on the stockticks 02/18/21 08:56:24 PM
#8217   $AIKI 18k@$1.55, I have a feeling tomorrow should FROZENFLAME 02/18/21 06:00:28 PM
#8216   Added 25k shares $1.57 hope this goes well :) Stockz12345 02/18/21 03:20:20 PM
#8215   Took a position at 1.68. Watching to mopartuck 02/18/21 07:19:13 AM
PostSubject
Consent Preferences